Join Paid Clinical Trials for Allergies in the United Kingdom

Paid Clinical Trials and Focus Groups by Category

All Categories ... by Medical Condition » ... Allergies » ... United Kingdom

Beta Blockers for the Treatment of Asthma

Condition: Asthma
Interventions: Drug: propranolol; Drug: placebo
Sponsors: University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2010
Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Condition: Asthma
Interventions: Drug: CHF 5188 pMDI; Drug: Budesonide extrafine pMDI; Drug: Seretide(r) Evohaler(r)
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2010
Reversal of Acute β-Blocker Induced Bronchoconstriction

Condition: Asthma
Intervention: Drug: Hydrocortisone/ Placebo and Propranolol
Sponsors: University of Dundee; NHS Tayside
Not yet recruiting - verified December 2009
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Condition: Asthma
Intervention: Biological: Mepolizumab (treatment) - Severe asthma
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Condition: Hereditary Angioedema
Intervention: Drug: Icatibant
Sponsor: Jerini AG
Recruiting - verified October 2009
Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers

Conditions: Asthma; Pulmonary Disease, Chronic Obstructive
Intervention: Other: Empty inhalers
Sponsor: Orion Corporation, Orion Pharma
Recruiting - verified February 2010
A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Condition: Asthma
Interventions: Drug: PF-03526299; Drug: Placebo; Drug: Fluticasone propionate
Sponsor: Pfizer
Recruiting - verified March 2010
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care

Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care

Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis

Condition: Bronchiectasis
Interventions: Drug: Inhaled mannitol; Drug: matched control
Sponsor: Pharmaxis
Recruiting - verified March 2010
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Condition: Cytomegalovirus Infections
Interventions: Drug: Placebo; Drug: Valganciclovir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

Condition: Pulmonary Hypertension
Interventions: Drug: bosentan; Drug: placebo
Sponsor: Actelion
Recruiting - verified March 2010

Join Paid Clinical Trials for Allergies in the United Kingdom - Clinical Trials

Join Paid Clinical Trials for Allergies in the United Kingdom

Paid Clinical Trials and Focus Groups by Category

Main Menu

Find Clinical Trials

Clinical Trial Locations

Clinical Trial Categories

Patient Recruiting...

Paid Clinical Trials